$MGNX
Macrogenics Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · Rockville, MD
MGNX chart
What traders are saying about $MGNX
Latest postsMacrogenics Inc news
- MacroGenics, Inc. (MGNX) Seasonal returns chart
Yahoo Finance UK ·
- MacroGenics to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- MacroGenics Inc earnings missed, revenue fell short of estimates
Investing.com ·
- MacroGenics Director Emil Kuriakose Granted Stock Options and RSUs in October 2026
Kalkine Media ·
- MacroGenics Announces Appointments of Emil Kuriakose, M.D., and Michael Vasconcelles, M.D., to Board of Directors
Yahoo Finance ·
- ResMed (RMD) Beats Q1 Earnings and Revenue Estimates
Yahoo Finance ·
- MacroGenics Announces Positive Interim Phase 2 LINNET Results for Lorigerlimab in Advanced Clear Cell Gynecologic Cancer
Yahoo Finance ·
- MacroGenics Announces Positive Interim Phase 1 Results for MGC026 and Highlights Plans to Initiate Front-Line Combination Study in SCCHN
Yahoo Finance ·
- MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors
Yahoo Finance ·
- Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
- Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?
Yahoo Finance ·
- MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Yahoo Finance ·
Macrogenics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $149.5M | $150.0M | $58.7M | $151.9M |
| Net income | -$74,620 | -$66,966 | -$9,058 | -$119.8M |
| Diluted EPS | $-1.18 | $-1.07 | $-0.15 | $-1.95 |
| Total assets (year end) | $256.8M | $261.7M | $298.4M | $280.5M |
| Cash and equivalents (year end) | $57.2M | $182.8M | $101.0M | $108.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Macrogenics Inc
- Ticker
- MGNX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1125345
Frequently asked questions
What exchange is Macrogenics Inc listed on?
Macrogenics Inc trades on the Nasdaq under the ticker symbol MGNX.
What industry is Macrogenics Inc in?
Macrogenics Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Macrogenics Inc headquartered?
Macrogenics Inc's business address on file with the SEC is in Rockville, MD.
When does Macrogenics Inc's fiscal year end?
Macrogenics Inc's fiscal year ends on December 31.
How much revenue did Macrogenics Inc report?
Macrogenics Inc reported $149.5M in revenue for calendar year 2025, according to its SEC filings.